TrialClinical and experimental hypertension (New York, N.Y. : 1993)2010

Pitavastatin further decreases serum high-sensitive C-reactive protein levels in hypertensive patients with hypercholesterolemia treated with angiotensin II, type-1 receptor antagonists.

Masamichi Yoshika et al.PubMed ↗Publisher ↗

No numbers read from the abstract.